EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Characterization of human intestinal organoid-derived monolayers under air-liquid interface culture for pharmacokinetics evaluation

Ilona Wehl, Kazuyoshi Michiba, Veronika Walser, Stefan Beck, Homam Tayfour, Tomoki Imaoka, Daisuke Nakai, Katja Damme, Ilona Schreck

Drug Metabolism and Disposition · 2026-06 · 54 (6) · 100308

DOI: 10.1016/j.dmd.2026.100308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026-06. Verfasst von Ilona Wehl und 8 weiteren Autor:innen. Beteiligte Einrichtung: Daiichi Sankyo Translational Research Center Europe, Daiichi Sankyo Europe GmbH, Martinsried, Germany. Hauptthemen laut MEDLINE: Organoids, Midazolam, Intestinal Mucosa. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intestinal organoid-derived monolayers have emerged as a novel in vitro model for investigating drug absorption and metabolism. Air-liquid interface (ALI) culture method enhances physiologically relevance of epithelial cells. In this study, we applied ALI culture to tissue stem cell-derived human intestinal organoids with the aim of achieving further improvement of their pharmacokinetic function. We established human duodenal and jejunal tissue-derived organoid monolayers under ALI culture using commercially available ready-to-use media and evaluated their utility for their pharmacokinetic application in comparison with conventional submerged monolayers. Although transepithelial electrical resistance values were significantly lower and more stable in ALI monolayers, monolayers under both conditions maintained barrier integrity as indicated by low apparent permeability of fluorescein-isothiocyanate dextran 4000, a paracellular transport marker. ALI monolayers exhibited markedly higher expression of CYP3A4 along with enhanced CYP3A activity than submerged monolayers. Correspondingly, an estimated intestinal availability value of midazolam, a CYP3A substrate, in ALI monolayers closely matched a reported human in vivo value, outperforming submerged monolayers. Activities of phase II metabolic enzymes (uridine 5'-diphospho-glucuronosyltransferase and sulfotransferases) and P-glycoprotein, as well as CYP3A4 and P-gp inducibility, were comparable between the culture conditions. Our findings demonstrate that ALI-cultured human intestinal organoid-derived monolayers provide a robust in vitro platform for investigating intestinal first-pass metabolism of CYP3A substrate drugs. SIGNIFICANCE STATEMENT: This study provides a detailed comparison of tissue-derived human intestinal organoid monolayers cultured under air-liquid interface (ALI) and conventional submerged conditions, focusing on their applicability in pharmacokinetic studies. Our findings highlight the enhanced capability of ALI monolayers to recapitulate CYP3A-mediated intestinal first-pass metabolism. Leveraging commercially available ready-to-use organoid culture media, the ALI model offers a practical and efficient platform for drug metabolism studies, facilitating broader adoption depending on specific research needs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsMidazolamIntestinal MucosaHumansCytochrome P-450 CYP3AIntestinal Barrier FunctionJejunumCell Culture TechniquesATP Binding Cassette Transporter, Subfamily B, Member 1Intestinal AbsorptionDuodenum

Stichwörter der Autor:innen

Air-liquid interfaceCYP3ADrug absorptionIntestinal bioavailabilityIntestinal metabolismIntestinal organoids

Substanzen

Cytochrome P-450 CYP3AMidazolamCYP3A4 protein, humanATP Binding Cassette Transporter, Subfamily B, Member 1

Autor:innen und Institutionen

  • Daiichi Sankyo Translational Research Center Europe, Daiichi Sankyo Europe GmbH, Martinsried, Germany.
  • Drug Metabolism and Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
  • Daiichi Sankyo Translational Research Center Europe, Daiichi Sankyo Europe GmbH, Martinsried, Germany. Electronic address: ilona.schreck@daiichisankyo.com.

Zitieren

APA

Wehl, I., Michiba, K., Walser, V., Beck, S., Tayfour, H., Imaoka, T., Nakai, D., Damme, K., & Schreck, I. (2026). Characterization of human intestinal organoid-derived monolayers under air-liquid interface culture for pharmacokinetics evaluation. Drug Metabolism and Disposition, 54(6), 100308. https://doi.org/10.1016/j.dmd.2026.100308

Vancouver

Wehl I, Michiba K, Walser V, Beck S, Tayfour H, Imaoka T, et al. Characterization of human intestinal organoid-derived monolayers under air-liquid interface culture for pharmacokinetics evaluation. Drug Metabolism and Disposition. 2026;54(6):100308. doi:10.1016/j.dmd.2026.100308

BibTeX
@article{Wehl2026,
  author = {Wehl, Ilona and Michiba, Kazuyoshi and Walser, Veronika and Beck, Stefan and Tayfour, Homam and Imaoka, Tomoki and Nakai, Daisuke and Damme, Katja and Schreck, Ilona},
  title = {Characterization of human intestinal organoid-derived monolayers under air-liquid interface culture for pharmacokinetics evaluation},
  journal = {Drug Metabolism and Disposition},
  year = {2026},
  volume = {54},
  number = {6},
  pages = {100308},
  doi = {10.1016/j.dmd.2026.100308}
}
Kostenlos starten →